Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

Item
http://www.wikidata.org/entity/Q36001930
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agentsEvolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative NeoplasmsClinical potential of pacritinib in the treatment of myelofibrosisNovel therapies for myelofibrosisA data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.Ruxolitinib for myelofibrosis--an update of its clinical effects.Advances in myelofibrosis: a clinical case approach.Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapy.Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms.The role of the extracellular matrix in primary myelofibrosis.Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation.Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview.HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.
P2860

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

Item
http://www.wikidata.org/entity/Q36001930
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@ast
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@en
type
label
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@ast
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@en
prefLabel
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@ast
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Epigenetic abnormalities in my ...... novel therapeutic strategies.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932